Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial general intelligence and the clinical laboratory: a paradigm shift toward Lab 2.0.

Clinical chemistry and laboratory medicine·2026
Same author

Alcohol interaction and ALDH2: missing links in EMPHASIS.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same author

Reassessing Treatment Outcomes Following Immune-Related Adverse Events.

JAMA oncology·2026
Same author

Nerandomilast in Patients with Pulmonary Fibrosis.

The New England journal of medicine·2025
Same author

A Comparison of Peripherally Inserted Central Catheter Materials.

The New England journal of medicine·2025
Same author

Public Attitudes toward COVID-19 Vaccinations before Dawn in Japan: Ethics and Future Perspectives.

Asian bioethics review·2022

Related Experiment Video

Updated: Apr 10, 2026

Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats
08:06

Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats

Published on: June 18, 2018

7.8K

Challenges in Interpreting MELATORCH Trial Outcomes

Koichiro Yuji1,2, Wakako Yuji2

  • 1Project Division of International Healthcare Innovation Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

JAMA Oncology
|April 9, 2026
PubMed
Summary

No abstract available in PubMed .

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

2.5K

Related Experiment Videos

Last Updated: Apr 10, 2026

Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats
08:06

Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats

Published on: June 18, 2018

7.8K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

2.5K